See more : ENM Holdings Limited (0128.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Endexx Corporation (EDXC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Endexx Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Pangaea Oncology, S.A. (PANG.MC) Income Statement Analysis – Financial Results
- SPK Corporation (7466.T) Income Statement Analysis – Financial Results
- Quadient S.A. (QDT.PA) Income Statement Analysis – Financial Results
- Digital Media Professionals Inc. (3652.T) Income Statement Analysis – Financial Results
- Royal Orchid Hotels Limited (ROHLTD.NS) Income Statement Analysis – Financial Results
Endexx Corporation (EDXC)
About Endexx Corporation
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.91M | 1.28M | 650.52K | 1.97M | 1.50M | 797.55K | 418.39K | 220.76K | 126.26K | 34.64K | 0.00 |
| Cost of Revenue | 5.06M | 774.57K | 994.59K | 606.62K | 823.58K | 449.25K | 212.46K | 166.54K | 115.72K | 732.00 | 0.00 |
| Gross Profit | -1.15M | 503.01K | -344.08K | 1.36M | 674.49K | 348.30K | 205.93K | 54.22K | 10.54K | 33.91K | 0.00 |
| Gross Profit Ratio | -29.39% | 39.37% | -52.89% | 69.22% | 45.02% | 43.67% | 49.22% | 24.56% | 8.35% | 97.89% | 0.00% |
| Research & Development | 5.25K | 27.07K | 10.15K | 15.27K | 20.72K | 43.64K | 8.11K | 18.74K | 57.47K | 115.99K | 2.00K |
| General & Administrative | 0.00 | 3.25M | 3.22M | 3.50M | 3.30M | 1.06M | 449.88K | 763.69K | 879.84K | 533.87K | 234.70K |
| Selling & Marketing | 0.00 | 564.08K | 1.78M | 445.14K | 255.90K | 108.10K | 52.27K | 41.83K | 36.97K | 59.38K | 0.00 |
| SG&A | 4.09M | 3.82M | 5.00M | 3.95M | 3.30M | 1.17M | 502.14K | 805.53K | 916.82K | 593.25K | 234.70K |
| Other Expenses | 0.00 | 20.61K | 20.40K | 15.45K | 25.18K | 65.05K | 2.64K | 2.64K | 67.72K | 35.78K | -599.00 |
| Operating Expenses | 4.09M | 3.87M | 5.03M | 3.98M | 3.35M | 1.22M | 512.90K | 826.92K | 976.72K | 710.32K | 237.07K |
| Cost & Expenses | 9.15M | 4.64M | 6.02M | 4.59M | 4.17M | 1.67M | 725.36K | 993.45K | 1.09M | 710.32K | 237.07K |
| Interest Income | 0.00 | 1.24M | 950.55K | 3.13M | 1.48M | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 |
| Interest Expense | 3.80M | 1.24M | 950.55K | 3.13M | 1.90M | 435.72K | 306.75K | 3.97K | 270.99K | 2.00 | 0.00 |
| Depreciation & Amortization | 9.67K | 20.61K | 20.40K | 15.45K | 17.42K | 10.64K | 2.64K | 2.64K | 2.43K | 1.08K | -374.00 |
| EBITDA | -4.67M | -3.65M | -5.37M | -5.73M | -6.78M | -1.33M | -276.13K | -770.05K | -896.03K | -674.60K | -236.70K |
| EBITDA Ratio | -119.45% | -352.65% | -1,020.65% | -146.48% | -585.00% | -100.28% | -72.74% | -348.83% | -709.65% | -2,616.83% | 0.00% |
| Operating Income | -5.24M | -3.36M | -5.37M | -2.62M | -2.67M | -867.48K | -306.97K | -772.70K | -966.18K | -675.68K | -237.07K |
| Operating Income Ratio | -134.08% | -263.17% | -825.70% | -132.73% | -178.50% | -108.77% | -73.37% | -350.02% | -765.21% | -1,950.57% | 0.00% |
| Total Other Income/Expenses | -3.23M | -1.23M | -1.44M | -5.45M | -3.99M | -1.63M | -361.76K | -3.97K | -84.16K | 267.66K | -599.00 |
| Income Before Tax | -8.47M | -4.13M | -6.81M | -8.06M | -9.66M | -1.74M | -668.73K | -776.66K | -1.17M | -408.02K | -237.67K |
| Income Before Tax Ratio | -216.81% | -323.19% | -1,046.58% | -409.01% | -644.73% | -217.94% | -159.83% | -351.82% | -926.20% | -1,177.88% | 0.00% |
| Income Tax Expense | -1.98M | 766.71K | 950.55K | 3.13M | 1.73M | -434.95K | 306.75K | -1.00 | 338.71K | -231.87K | 747.00 |
| Net Income | -6.50M | -4.90M | -7.76M | -11.19M | -11.39M | -1.74M | -668.73K | -776.66K | -1.17M | -408.02K | -237.67K |
| Net Income Ratio | -166.26% | -383.20% | -1,192.70% | -567.92% | -760.28% | -217.94% | -159.83% | -351.82% | -926.20% | -1,177.89% | 0.00% |
| EPS | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 504.71M | 503.98M | 455.05M | 379.17M | 343.49M | 289.10M | 259.70M | 235.54M | 216.32M | 211.71M | 199.04M |
| Weighted Avg Shares Out (Dil) | 504.71M | 503.98M | 455.05M | 379.17M | 343.49M | 289.10M | 262.47M | 235.54M | 216.32M | 211.71M | 199.04M |
Endexx to Present at the LD Micro Invitational XII Four Seasons Westlake Village June 7-9th
CAVE CREEK, AZ, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTC: EDXC), a provider of innovative Hemp-derived wellness, skin care and nutritional products, is pleased to announce that Endexx is presenting at the LD Micro Invitational...
Endexx says three Blesswell facial products available at CVS Health stores
Endexx Corporation has announced that three facial products of the Blesswell skincare line are now available at select CVS Health stores and online at www.CVS.com. Launched in May of 2021 in partnership with Endexx, the Blesswell collection is designed to...
Endexx to Present at the Lytham Partners Fall 2021 Investor Conference October 6th and 7th
Also Presenting at the LD Micro Main Event October 12th
DJ Khaled's BLESSWELL™ Pops Up in the Windy City
CHICAGO, Sept. 27, 2021 /PRNewswire/ -- GRAMMY® Award-winning artist and wellness guru DJ Khaled is bringing his CBD-infused skincare to fans with GROOMED x BLESSWELL ™ Chicago.
CBD Unlimited Exhibiting at Natural Products Expo East 2021
CAVE CREEK, AZ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (EDXC), a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce the Company will be presenting at the Natural Products Expo East taking...
Endexx Tests New Shareholder Communications Platform in EDXC LIVE
Endexx Provides Shareholder Update on Previously Disclosed Corporate Actions
Endexx Tests New Shareholder Communications Platform in EDXC LIVE
Endexx Provides Shareholder Update on Previously Disclosed Corporate ActionsCave Creek, Arizona--(Newsfile Corp. - September 15, 2021) - Endexx® Corporation (OTC Pink: EDXC), a leading producer and manufacturer of hemp-derived CBD wellness products since 2014, presented a corporate update at invitation...
Endexx's International Division, Go Green Global, Initiates Soft-Launch of its Herb House Dispensary in Ocho Rios, Jamaica
Cave Creek, AZ, Aug. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a provider of innovative Hemp-derived wellness and nutritional products, is pleased to announce the soft launch of a new “Herb House” in Ocho Rios,...
Endexx Corporation and DJ Khaled's BLESSWELL Shows Strong Promise in the CBD Wellness Sector Within First Months of Debut
Partnering with famed Hollywood brand Von Dutch to host a star-studded Summer Fridays Kickoff experience
Endexx reveals significant corporate progress so far in 2021 as it passes a key financial test
Endexx Corporation (OTCMKTS:EDXC) has revealed significant corporate progress so far in 2021 as it passes a key financial test. The lifestyle company, focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based wellness products, announced that the United States Securities...
Source: https://incomestatements.info
Category: Stock Reports